vs
Side-by-side financial comparison of CAMDEN NATIONAL CORP (CAC) and HARROW, INC. (HROW). Click either name above to swap in a different company.
HARROW, INC. is the larger business by last-quarter revenue ($89.1M vs $64.3M, roughly 1.4× CAMDEN NATIONAL CORP). CAMDEN NATIONAL CORP runs the higher net margin — 34.0% vs 7.4%, a 26.6% gap on every dollar of revenue. Over the past eight quarters, HARROW, INC.'s revenue compounded faster (60.5% CAGR vs 22.6%).
Camden National Bank is a commercial bank headquartered in Camden, Maine, operating as the principal subsidiary of Camden National Corporation, a publicly traded bank holding company. Founded in 1875, the bank became a direct, wholly owned subsidiary of the holding company following a corporate reorganization in 1984. Following the 2025 merger with Northway Financial, the combined institution has approximately $7.0 billion in assets.
Harrow Health, Inc., formerly known as Imprimis Pharmaceuticals, is a publicly traded pharmaceutical company based in Nashville, Tennessee.
CAC vs HROW — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $64.3M | $89.1M |
| Net Profit | $21.9M | $6.6M |
| Gross Margin | — | 79.3% |
| Operating Margin | — | 17.5% |
| Net Margin | 34.0% | 7.4% |
| Revenue YoY | — | 33.3% |
| Net Profit YoY | — | -2.2% |
| EPS (diluted) | $1.29 | $0.20 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $89.1M | ||
| Q3 25 | $65.4M | $71.6M | ||
| Q2 25 | $62.3M | $63.7M | ||
| Q1 25 | $60.1M | $47.8M | ||
| Q4 24 | $47.6M | $66.8M | ||
| Q3 24 | $45.0M | $49.3M | ||
| Q2 24 | $42.8M | $48.9M |
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $6.6M | ||
| Q3 25 | $21.2M | $1.0M | ||
| Q2 25 | $14.1M | $5.0M | ||
| Q1 25 | $7.3M | $-17.8M | ||
| Q4 24 | $14.7M | $6.8M | ||
| Q3 24 | $13.1M | $-4.2M | ||
| Q2 24 | $12.0M | $-6.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | 79.3% | ||
| Q3 25 | — | 75.3% | ||
| Q2 25 | — | 74.5% | ||
| Q1 25 | — | 67.5% | ||
| Q4 24 | — | 78.8% | ||
| Q3 24 | — | 75.6% | ||
| Q2 24 | — | 74.4% |
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | 17.5% | ||
| Q3 25 | 40.5% | 20.6% | ||
| Q2 25 | 28.5% | 17.9% | ||
| Q1 25 | 10.3% | -23.5% | ||
| Q4 24 | 38.7% | 19.3% | ||
| Q3 24 | 35.2% | 2.7% | ||
| Q2 24 | 34.7% | 3.1% |
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | 7.4% | ||
| Q3 25 | 32.4% | 1.4% | ||
| Q2 25 | 22.6% | 7.8% | ||
| Q1 25 | 12.2% | -37.2% | ||
| Q4 24 | 30.8% | 10.1% | ||
| Q3 24 | 29.1% | -8.6% | ||
| Q2 24 | 28.0% | -13.2% |
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $0.20 | ||
| Q3 25 | $1.25 | $0.03 | ||
| Q2 25 | $0.83 | $0.13 | ||
| Q1 25 | $0.43 | $-0.50 | ||
| Q4 24 | $1.00 | $0.19 | ||
| Q3 24 | $0.90 | $-0.12 | ||
| Q2 24 | $0.81 | $-0.18 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $72.9M |
| Total DebtLower is stronger | $514.4M | $250.0M |
| Stockholders' EquityBook value | $710.0M | $52.4M |
| Total Assets | $7.0B | $399.5M |
| Debt / EquityLower = less leverage | 0.72× | 4.77× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | — | $72.9M | ||
| Q3 25 | — | $74.3M | ||
| Q2 25 | — | $53.0M | ||
| Q1 25 | — | $66.7M | ||
| Q4 24 | — | $47.2M | ||
| Q3 24 | — | $72.6M | ||
| Q2 24 | — | $71.0M |
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | $250.0M | ||
| Q3 25 | — | $347.2M | ||
| Q2 25 | — | $250.6M | ||
| Q1 25 | — | $256.9M | ||
| Q4 24 | — | $262.7M | ||
| Q3 24 | — | $230.7M | ||
| Q2 24 | — | $236.3M |
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $52.4M | ||
| Q3 25 | $676.4M | $47.0M | ||
| Q2 25 | $652.1M | $49.7M | ||
| Q1 25 | $640.1M | $56.5M | ||
| Q4 24 | $531.2M | $69.7M | ||
| Q3 24 | $529.9M | $58.0M | ||
| Q2 24 | $508.3M | $58.5M |
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $399.5M | ||
| Q3 25 | $7.0B | $363.1M | ||
| Q2 25 | $6.9B | $345.0M | ||
| Q1 25 | $7.0B | $364.2M | ||
| Q4 24 | $5.8B | $389.0M | ||
| Q3 24 | $5.7B | $351.5M | ||
| Q2 24 | $5.7B | $306.6M |
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | 4.77× | ||
| Q3 25 | — | 7.39× | ||
| Q2 25 | — | 5.05× | ||
| Q1 25 | — | 4.55× | ||
| Q4 24 | — | 3.77× | ||
| Q3 24 | — | 3.98× | ||
| Q2 24 | — | 4.04× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $8.4M |
| Free Cash FlowOCF − Capex | — | $8.1M |
| FCF MarginFCF / Revenue | — | 9.1% |
| Capex IntensityCapex / Revenue | — | 0.4% |
| Cash ConversionOCF / Net Profit | — | 1.27× |
| TTM Free Cash FlowTrailing 4 quarters | — | $43.0M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $8.4M | ||
| Q3 25 | $36.1M | $16.6M | ||
| Q2 25 | $6.0M | $-803.0K | ||
| Q1 25 | $1.0M | $19.7M | ||
| Q4 24 | $60.9M | $-17.8M | ||
| Q3 24 | $-14.5M | $3.0M | ||
| Q2 24 | $14.5M | $-2.7M |
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | $8.1M | ||
| Q3 25 | $35.4M | $16.4M | ||
| Q2 25 | $4.5M | $-969.0K | ||
| Q1 25 | $-727.0K | $19.5M | ||
| Q4 24 | $55.4M | $-18.3M | ||
| Q3 24 | $-16.2M | $2.3M | ||
| Q2 24 | $13.2M | $-3.1M |
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | 9.1% | ||
| Q3 25 | 54.1% | 22.9% | ||
| Q2 25 | 7.3% | -1.5% | ||
| Q1 25 | -1.2% | 40.8% | ||
| Q4 24 | 116.4% | -27.4% | ||
| Q3 24 | -36.0% | 4.8% | ||
| Q2 24 | 30.8% | -6.3% |
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | 0.4% | ||
| Q3 25 | 1.1% | 0.3% | ||
| Q2 25 | 2.4% | 0.3% | ||
| Q1 25 | 2.9% | 0.4% | ||
| Q4 24 | 11.7% | 0.8% | ||
| Q3 24 | 3.8% | 1.2% | ||
| Q2 24 | 3.0% | 0.7% |
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | 1.27× | ||
| Q3 25 | 1.70× | 16.26× | ||
| Q2 25 | 0.43× | -0.16× | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | -2.62× | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
HROW
Segment breakdown not available.
